» Articles » PMID: 34944651

Heart-Brain Relationship in Stroke

Overview
Journal Biomedicines
Date 2021 Dec 24
PMID 34944651
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The patient presenting with stroke often has cardiac-related risk factors which may be involved in the mechanism of the stroke. The diagnostic assessment is predicated on recognition of this potential relationship. Naturally, an accurate history is of utmost importance in discerning a possible cause and effect relationship. The EKG is obviously an important clue as well as it allows immediate assessment for possible cardiac arrhythmia, such as atrial fibrillation, for possible acute ischemic changes reflective of myocardial ischemia, or there may be indirect factors such as the presence of left ventricular hypertrophy, typically seen with longstanding hypertension, which could be indicative of a hypertensive mechanism for a patient presenting with intracerebral hemorrhage. For all presentations in the emergency room, the vital signs are important. An elevated body temperature in a patient presenting with acute stroke raises concern about possible infective endocarditis. An irregular-irregular pulse is an indicator of atrial fibrillation. A markedly elevated blood pressure is not uncommon in both the acute ischemic and acute hemorrhagic stroke setting. One tends to focus on possible cardioembolic stroke if there is the sudden onset of maximum neurological deficit versus the stepwise progression more characteristic of thrombotic stroke. Because of the more sudden loss of vascular supply with embolic occlusion, seizure or syncope at onset tends to be supportive of this mechanism. Different vascular territory involvement on neuroimaging is also a potential indicator of cardioembolic stroke. Identification of a cardiogenic source of embolus in such a setting certainly elevates this mechanism in the differential. There have been major advances in management of acute cerebrovascular disease in recent decades, such as thrombolytic therapy and endovascular thrombectomy, which have somewhat paralleled the advances made in cardiovascular disease. Unfortunately, the successful limitation of myocardial damage in acute coronary syndrome, with intervention, does not necessarily mirror a similar salutary effect on functional outcome with cerebral infarction. The heart can also affect the brain from a cerebral perfusion standpoint. Transient arrhythmias can result in syncope, while cardiac arrest can result in hypoxic-ischemic encephalopathy. Cardiogenic dementia has been identified as a mechanism of cognitive impairment associated with severe cardiac failure. Structural cardiac abnormalities can also play a role in brain insult, and this can include tumors, such as atrial myxoma, patent foramen ovale, with the potential for paradoxical cerebral embolism, and cardiomyopathies, such as Takotsubo, can be associated with precipitous cardioembolic events.

Citing Articles

Association Between Diurnal Temperature Range and Risk of Cardiomyopathy-Induced Hospitalisation in Henan, China: A Time-Series Study.

Zhang Z, Wang Y, Zhou Y, Pei J, Zhao G, Dong P Risk Manag Healthc Policy. 2025; 18:279-290.

PMID: 39867988 PMC: 11761851. DOI: 10.2147/RMHP.S502132.


Analysis of Clinical Symptoms and Risk Factors Related to Functional Prognosis in Patients With Cardiogenic Stroke.

Liu P, Liu S, Yuan P Tex Heart Inst J. 2024; 51(2):e248428.

PMID: 39720631 PMC: 11666877. DOI: 10.14503/THIJ-24-8428.


Cognitive Impairment and Synaptic Dysfunction in Cardiovascular Disorders: The New Frontiers of the Heart-Brain Axis.

Soda T, Pasqua T, De Sarro G, Moccia F Biomedicines. 2024; 12(10).

PMID: 39457698 PMC: 11504205. DOI: 10.3390/biomedicines12102387.


A Bidirectional Mendelian Randomization Study of the Causal Association Between Ischemic Stroke, Coronary Heart Disease, and Hydrocephalus.

Wang W, Liu M, Wang Z, Ma L, Zhao Y, Ye W Brain Behav. 2024; 14(10):e70090.

PMID: 39378279 PMC: 11460635. DOI: 10.1002/brb3.70090.


Impact of Concurrent Ischaemic Stroke on Unfavourable Outcomes in Men and Women with Dilated Cardiomyopathy.

Fan Z, Wu C, Wang C, Liu C, Fang L, Ma L Rev Cardiovasc Med. 2024; 25(6):215.

PMID: 39076319 PMC: 11270057. DOI: 10.31083/j.rcm2506215.


References
1.
Fuster V, Ryden L, Cannom D, Crijns H, Curtis A, Ellenbogen K . 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice.... J Am Coll Cardiol. 2011; 57(11):e101-98. DOI: 10.1016/j.jacc.2010.09.013. View

2.
Guimaraes H, Lopes R, de Barros E Silva P, Liporace I, Sampaio R, Tarasoutchi F . Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. N Engl J Med. 2020; 383(22):2117-2126. DOI: 10.1056/NEJMoa2029603. View

3.
Reddy V, Doshi S, Sievert H, Buchbinder M, Neuzil P, Huber K . Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013; 127(6):720-9. DOI: 10.1161/CIRCULATIONAHA.112.114389. View

4.
Thuny F, Avierinos J, Tribouilloy C, Giorgi R, Casalta J, Milandre L . Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J. 2007; 28(9):1155-61. DOI: 10.1093/eurheartj/ehm005. View

5.
Dutta T, Karas M, Segal A, Kizer J . Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia. Am J Cardiol. 2006; 97(6):894-8. DOI: 10.1016/j.amjcard.2005.09.140. View